Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study - PubMed (original) (raw)
Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study
Kati Pentti et al. Maturitas. 2009.
Abstract
Background: To analyse prospectively the effect of calcium or calcium+D supplementation on coronary heart disease (CHD) in 52-62-year-old women.
Methods and results: 10,555 52-62-year-old women from the population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE) who did not have CHD at baseline were followed for nearly 7 years in 1994-2001. Information about use of calcium supplements and health events was obtained from two repeated questionnaires in 1989 and 1994. Information about causes of death during the follow-up was obtained from the Statistics Finland. Information about CHD and other disease morbidity before and during the follow-up was obtained from the Registry of Specially Refunded Drugs of the Finnish Social Insurance Institution (SII). Cox's proportional-hazards models were used to estimate the risk of CHD morbidity related to the use of calcium supplements. At baseline, 2723 women reported current use of calcium or calcium+D supplementation. During the follow-up, CHD was diagnosed in 513 women. Compared to non-users of calcium/calcium+D supplements, the multivariate adjusted hazard ratio (HR) of CHD was 1.24 (95% CI 1.02-1.52) in women who used these supplements. The multivariate adjusted HR for CHD morbidity in postmenopausal women who used calcium/calcium+D supplements was 1.26 (95% CI 1.01-1.57).
Conclusions: Calcium or calcium+D supplementation appears to increase the risk of CHD among women before old age.
Similar articles
- Effect of vitamin D(3) and calcium on fracture risk in 65- to 71-year-old women: a population-based 3-year randomized, controlled trial--the OSTPRE-FPS.
Salovaara K, Tuppurainen M, Kärkkäinen M, Rikkonen T, Sandini L, Sirola J, Honkanen R, Alhava E, Kröger H. Salovaara K, et al. J Bone Miner Res. 2010 Jul;25(7):1487-95. doi: 10.1002/jbmr.48. J Bone Miner Res. 2010. PMID: 20200964 Clinical Trial. - Modifiable risk factors have an impact on socio-economic differences in coronary heart disease events.
Harald K, Pajunen P, Jousilahti P, Koskinen S, Vartiainen E, Salomaa V. Harald K, et al. Scand Cardiovasc J. 2006 Apr;40(2):87-95. doi: 10.1080/14017430500519872. Scand Cardiovasc J. 2006. PMID: 16608778 - A high menaquinone intake reduces the incidence of coronary heart disease.
Gast GC, de Roos NM, Sluijs I, Bots ML, Beulens JW, Geleijnse JM, Witteman JC, Grobbee DE, Peeters PH, van der Schouw YT. Gast GC, et al. Nutr Metab Cardiovasc Dis. 2009 Sep;19(7):504-10. doi: 10.1016/j.numecd.2008.10.004. Epub 2009 Jan 28. Nutr Metab Cardiovasc Dis. 2009. PMID: 19179058 - Is calcium supplementation a risk factor for cardiovascular diseases in older women?
Sabbagh Z, Vatanparast H. Sabbagh Z, et al. Nutr Rev. 2009 Feb;67(2):105-8. doi: 10.1111/j.1753-4887.2008.00146.x. Nutr Rev. 2009. PMID: 19178652 Review. - Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis.
Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Bolland MJ, et al. BMJ. 2011 Apr 19;342:d2040. doi: 10.1136/bmj.d2040. BMJ. 2011. PMID: 21505219 Free PMC article. Review.
Cited by
- Acute effects of calcium supplements on blood pressure: randomised, crossover trial in postmenopausal women.
Billington EO, Bristow SM, Gamble GD, de Kwant JA, Stewart A, Mihov BV, Horne AM, Reid IR. Billington EO, et al. Osteoporos Int. 2017 Jan;28(1):119-125. doi: 10.1007/s00198-016-3744-y. Epub 2016 Aug 20. Osteoporos Int. 2017. PMID: 27543500 Clinical Trial. - Cardiovascular effects of calcium supplements.
Reid IR. Reid IR. Nutrients. 2013 Jul 5;5(7):2522-9. doi: 10.3390/nu5072522. Nutrients. 2013. PMID: 23857224 Free PMC article. Review. - A Dairy Product to Reconstitute Enriched with Bioactive Nutrients Stops Bone Loss in High-Risk Menopausal Women without Pharmacological Treatment.
Morato-Martínez M, López-Plaza B, Santurino C, Palma-Milla S, Gómez-Candela C. Morato-Martínez M, et al. Nutrients. 2020 Jul 24;12(8):2203. doi: 10.3390/nu12082203. Nutrients. 2020. PMID: 32722015 Free PMC article. Clinical Trial. - The Bone-Vasculature Axis: Calcium Supplementation and the Role of Vitamin K.
Wasilewski GB, Vervloet MG, Schurgers LJ. Wasilewski GB, et al. Front Cardiovasc Med. 2019 Feb 5;6:6. doi: 10.3389/fcvm.2019.00006. eCollection 2019. Front Cardiovasc Med. 2019. PMID: 30805347 Free PMC article. Review. - Calcium intake and risk of cardiovascular disease: a review of prospective studies and randomized clinical trials.
Wang L, Manson JE, Sesso HD. Wang L, et al. Am J Cardiovasc Drugs. 2012 Apr 1;12(2):105-16. doi: 10.2165/11595400-000000000-00000. Am J Cardiovasc Drugs. 2012. PMID: 22283597 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical